www.ndcvalidator.com
National Drug Code Lookup
|
NDC Directory
|
About
|
Feedback
"58160-830-34" National Drug Code (NDC)
Cervarix 1 SYRINGE in 1 CARTON (58160-830-34) > .5 mL in 1 SYRINGE (58160-830-05)
(GlaxoSmithKline Biologicals SA)
NDC Code
58160-830-34
Package Description
1 SYRINGE in 1 CARTON (58160-830-34) > .5 mL in 1 SYRINGE (58160-830-05)
Product NDC
58160-830
Product Type Name
VACCINE
Proprietary Name
Cervarix
Non-Proprietary Name
Human Papillomavirus Bivalent (types 16 And 18) Vaccine, Recombinant
Dosage Form
INJECTION, SUSPENSION
Usage
INTRAMUSCULAR
Start Marketing Date
20091016
Marketing Category Name
BLA
Application Number
BLA125259
Manufacturer
GlaxoSmithKline Biologicals SA
Substance Name
HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN RESIDUES 2-471 ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN RESIDUES 2-472 ANTIGEN
Strength
20; 20
Strength Unit
ug/.5mL; ug/.5mL
Find more :
http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/58160-830-34